Labotec awarded Thermofisher Scientific SU Bioproduction agency for Southern Africa

Labotec is proud to announce a new partnership with Thermofisher Scientific as a trusted distributor of its Bioproduction portfolio for southern Africa. Labotec and ThermoFisher Scientific are able to provide an open-architecture solution through (SU) single-use bioproduction technologies and consumables for research and development for biotherapeutic producers in pharmaceutical products such as vaccines, monoclonal antibodies (mAbs), personalised medicine, and others.

Synergies for success

Through the Thermofisher Scientific worldwide manufacturing network, which is present in more than 100 countries on six continents and equipped with state-of-theart ISO 9001:2015 certified facilities that meet rigorous quality standards, combined with Labotec’s decades of experience in this field locally; the alliance is resolute in supporting the local markets need for highquality products, a stable supply chain and robust risk mitigation strategies for both up and down scale processes.

Bioprocessing by design

This is emphasised by Thermofisher Scientific to drive performance through collaboration with clients to deliver optimal customised solutions by integrating existing resources, understanding challenges, improve up or down scaling processes and enhance speed and quality. At the same time, the biotherapeutic market is rapidly adopting single use bioprocessing technologies due to efficiency in mitigating and reducing risk to improve operational efficiencies. This robust and scalable architecture from lab/ scale-up to cGMP production uses several disposable products; such as bioreactors, tangential-flow filtration devices, depth filters, disposable filter cartridges, media bags and containers, and mixing systems for upstream as well as downstream processing. Factors that boost the growth of the single-use bioprocessing market include increase in demand for biopharmaceuticals, validation pressures, rise in adoption of disposable technologies, low risk of product cross-contamination attributed to SUB technologies, and less floor space requirement.

Vaccine development for SARS-CoV-2

Even before the current global pandemic, Thermofisher Scientific has been at the forefront in vaccine development through its single-use bioproduction technologies and the associated bioprocessing consumables. With vaccine development now in the spotlight of scientific and medical research, Labotec and Thermofisher Scientific are able to provide an open-architecture solution to those in vaccine research and development.

LABOTEC (PTY) LTD

JHB: (011) 315 5434 CPT: (021) 531 7660 DBN: (031) 566 4870 Fax: (011) 315 5882 sales@labotec.co.za www.labotec.co.za